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Barriers and Facilitators to Use of a Clinical Evidence Technology in the Management of 
Skin Problems in Primary Care: Insights from Mixed Methods 
ABSTRACT 
Objective: Few studies have examined the impact of a single clinical evidence technology 
(CET) on provider practice or patient outcomes from the provider’s perspective. A previous 
cluster-randomized controlled trial with patient-reported data tested the effectiveness of a CET 
(i.e., VisualDx) in improving skin problem outcomes but found no significant effect. The 
objectives of this follow-up study were to identify barriers and facilitators to the use of the CET 
from the perspective of primary care providers (PCPs) and to identify reasons why the CET did 
not affect outcomes in the trial. 
Methods: Using a convergent mixed methods design, PCPs completed a post-trial survey and 
participated in interviews about using the CET for the management of patients’ skin problems. 
Data from both methods were integrated. 
Results: PCPs found the CET somewhat easy to use but only occasionally useful. Less 
experienced PCPs used the CET more frequently. Data from interviews revealed barriers and 
facilitators at four steps of evidence-based practice: clinical question recognition, information 
acquisition, appraisal of relevance, and application with patients. Facilitators included 
uncertainty in dermatology, intention for use, convenience of access, diagnosis and treatment 
support, and patient communication. Barriers included confidence in dermatology, preference for 




Conclusion: PCPs found the CET useful for diagnosis, treatment support, and patient 
communication. However, the barriers of interface difficulties, irrelevant search results, and 
preferred use of other sources limited its positive impact on patient skin problem management. 
Keywords entered in JMLA: 
Evidence-Based Medicine; Evidence-Based Practice; Decision-Support Systems; Medical 
Informatics Applications; Libraries, Hospital; Information Storage and Retrieval; Databases, 
Factual; Information-Seeking Behavior; Skin Diseases; Primary Health Care; Technology 






Clinical evidence technologies (CETs) are information sources derived from medical research 
literature that assist health care providers in continued learning, decision-making, and patient 
care. Evidence-based medicine (EBM), defined as “the integration of best research evidence with 
clinical expertise and patient values” [1], endorses the use of research-based evidence found in 
CETs, including medical journals, databases, clinical guidelines, and synthesized clinical 
summaries, to find evidence for patient care. Clinicians report referencing CETs and using the 
information therein to make better diagnosis and treatment decisions [2-4]. However, they also 
report barriers to answering their clinical questions, such as poor technology access, lack of 
relevant evidence sources, and time constraints [5-7].  
 Dermatology is an area of concern in primary care for which previous literature 
extensively discusses the goals of improving diagnostic accuracy, improving the management of 
skin disease, and reducing referrals [8-12]. Some studies in primary care and hospital settings 
show that a dermatology education toolkit [13] and diagnostic support CET [14] can improve 
provider confidence and diagnostic accuracy. However, few studies have examined the impact of 
a single CET on provider practice or patient outcomes from the provider’s perspective. The 
present study followed up on a previous cluster-randomized controlled trial to understand why 
and how primary care providers (PCPs) use a CET, VisualDx, to care for skin disease patients 
[15]. VisualDx, a factual knowledge database and diagnostic tool, matches patient symptoms 
with images to suggest likely diagnoses and management strategies [16]. In the original trial, 32 
PCPs were randomly assigned to use or not use VisualDx, and over 400 of their patients with 
skin complaints were interviewed about the outcomes of their primary care visit. PCP 
participation in the original trial averaged six months. Study results showed that VisualDx use 
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did not have a significant effect on the resolution of symptoms or the number of return 
appointments.  
The objectives of this follow-up investigation were two-fold: (1) to identify barriers and 
facilitators to PCPs’ use of the CET in a patient care context and (2) to gain insight from PCP 
reports into why CET use did not affect patient-level outcomes.  
METHODS  
We used a convergent, mixed methods design [17] in which we combined a quantitative survey 
with qualitative interviews to realize a more complete understanding of PCP experiences using 
the CET in a complex patient care setting. The methods had equal priority and were conducted 
concurrently in February and March of 2018, 19-20 months after PCPs’ participation in the 
original trial had concluded.  
   We followed the guidelines of O’Cathain et al. for the reporting of mixed methods to enhance 
the clarity of the methodology and analysis presentation [18]. The University of Vermont 
Institutional Review Board approved the original clinical trial, including baseline and post-
surveys of PCPs in May 2015 and the qualitative interview investigation in January 2018.  
 Participants included faculty and residents in family medicine and internal medicine 
primary care clinics who participated in the original trial. All PCPs in the original trial were 
invited to participate in the closed-answer post-trial survey, which was administered online or in-
person (Appendix A). Data were entered and stored in REDCap [19]. Demographic data, 
including years in practice, resident vs. attending status, family medicine vs. internal medicine 
status, and gender, were collected in the baseline survey of the original trial. Questions in the 
post-trial survey varied by participant arm. All PCPs were queried on their use of VisualDx 
during and after the trial and their use of other information sources after the trial. PCPs in the 
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CET arm were also asked about the number of times used, ease of use, and usefulness of 
VisualDx. The survey instrument design was informed by the technology acceptance model, 
which posits that intention, perceived ease of use, and perceived usefulness are important factors 
for acceptance and continued use of technologies introduced in the workplace [20]. Survey data 
were analyzed with descriptive statistics in Stata version 14.2 [21].  
 PCPs in the CET arm also participated in a semi-structured interview conducted in-
person and digitally recorded by the principal investigator (PI) (Appendix B). Interviews were 
transcribed by the PI and a research assistant. We chose a behavioral steps model based on the 
EBM paradigm to inform the semi-structured interview instrument design and frame the analysis 
of qualitative data (Figure 1). The EBM paradigm includes sequential behavioral steps taken by 
clinicians to find and apply the best available evidence. These steps, as described in EBM 
textbooks [1, 22] and reaffirmed by expert teaching and clinician panels [23], are: (1) ask clinical 
questions when uncertainty arises, (2) acquire the best available evidence, (3) appraise and 
interpret the evidence found, and (4) apply evidence considering patient values and preferences 
[22, 23]. The PI conducted initial coding of PCP statements using NVivo version 12 qualitative 
analysis software [24]. The PI and two independent team members then refined codes and 
identified emergent themes. Final themes were decided by team consensus. We organized themes 






Figure 1: Behavioral steps model based on the EBM paradigm.  
  
 To integrate the quantitative and qualitative results, we compared survey results on ease 
of use and usefulness to interview themes using the triangulation protocol described by 
O’Cathain et al. [25], which utilizes concepts of convergence, complementarity, dissonance, and 
silence to compare findings between methods in mixed methods studies. 
RESULTS  
Quantitative Survey Results  
Twenty-one of the 32 (66%) PCPs in the original trial participated in the post-trial survey: 13 of 
17 (76%) in the CET arm, and 8 of 15 (53%) in the control arm (Table 1). 
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Table 1: Characteristics of PCPs and CET usage in post-trial survey  
 All  CET Control 
n 21 13 8 
Gender (Men), n (%) 10 (47%) 6 (46%) 4 (50%) 
Resident (vs. Attending), n (%) 4 (10%) 4 (31%) 0 
Family Med (vs. Internal Med), n (%) 10 (47%) 5 (38%) 5 (63%) 
PCP Education    
Physician, n (%) 20 (95%) 13 (100%) 7 (88%) 
Advanced Practice Nurse, n (%) 1 (5%) 0 1 (12%) 
Years in Practice    
Median 17 12 18 
Range 1-40 1-40 2-39 
Followed VisualDx Usage Protocol in 
the Trial, n (%) 
20 (95%) 13 (100%) 7 (88%) 
Times used VisualDx During the Trial    
Median  10 --- 
Range  3-125 --- 
Used VisualDx After the Trial (yes), n 
(%) 
14 (67%) 9 (70%) 5 (63%) 
 
Protocol Fidelity and Frequency  
PCPs in the CET arm used VisualDx during the trial, whereas PCPs in the control arm, with one 
exception, did not, indicating protocol fidelity in both arms. PCPs in the CET arm used VisualDx 
a median of 10 times in the 6-month average trial participation period. Nearly half of CET arm 
PCPs (46%) reported using VisualDx with most of their patients with skin problems.  
Ease of Use and Usefulness   
Of the CET arm PCPs, ten (77%) described VisualDx as “somewhat easy” or “very easy” to use, 
whereas three (23%) found it “somewhat difficult” or “difficult” to use. When asked how useful 
VisualDx was for diagnosing and treating patients, five PCPs (38%) responded “usually”, five 
(38%) responded occasionally, and three (23%) responded “not at all”; none found it “always” 
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useful. These findings indicate that the CET was perceived as more easy to use than actually 
useful (Table 2). 
Years in Practice  
Compared with more experienced PCPs, PCPs with 5 or fewer years in practice used the CET 
more often (median 10 vs. 15 times) and were more likely to use the CET with more than half of 
their patients (67% vs. 29%). All (100%) of less experienced PCPs found the CET very or 
somewhat easy to use (100%) compared with 57% of more experienced PCPs (Table 2). 
Table 2: CET frequency of use, ease of use, and usefulness depending on years in practice  






N 13 6 7 
VisualDx Use during the trial, 
median uses (range) 
10 (3-125) 15 (5-30) 10 (3-125) 
Used VisualDx with >50% of skin 
patients, n (%) 
6 (46) 4 (67) 2 (29) 
Ease of use, n (%)     
  Very or somewhat difficult 3 (23) 0 (0) 3 (43) 
   Very or somewhat easy 10 (77) 6 (100) 4 (57) 
Usefulness, n (%)     
Not at all or occasionally useful 8 (62) 3 (50) 5 (71) 
Usually or always useful  5 (38) 3 (50) 2 (29) 
  
Usage of VisualDx and Other CETs Post-Trial 
Two-thirds (67%) of PCPs used VisualDx after the trial, and all (100%) used other information 
sources for the care of patients with skin problems. In a typical month post-trial, six PCPs (29%) 
reported using VisualDx, eleven (52%) used UpToDate, six used textbooks, four used Google, 
one used Epocrates, and one used DynaMed. None used PubMed/MEDLINE, other citation 





Qualitative Interview Results 
Eleven CET arm PCPs participated in an interview, including three residents and eight attending 
physicians who had been in practice for 1-40 years. We organized PCP interview statements into 
facilitator and barrier themes and noted the behavioral step context of the statement. Facilitator 
themes included intention to use the CET, uncertainty in dermatology, electronic health record 
(EHR) access, diagnosis/treatment support, and patient communication. Barrier themes included 
confidence in dermatology, time pressure, interface difficulties, use of other preferred sources, 
irrelevant information, and lack of impact on patient care. Below, we present facilitators and 
barriers to use of the CET at each behavioral step of the EBM model, with representative PCP 
statements presented in Table 3.  
Step 1: Ask a Clinical Question  
Facilitators to using the CET at this step were uncertainty in dermatology and intention to use the 
CET with skin problem patients. Some PCPs recognized uncertainty in dermatology, especially 
the diagnosis of rashes, as an area of concern due to less training and fewer rigorous approaches 
than in other domains. Several residents stated that because of such uncertainty, evidence-based 
information resources in dermatology were especially needed. One resident expressed her 
intention to use the CET from the beginning and estimated that she used it with nearly all her 
patients with skin problems.  
 Barriers to using the CET at this step were confidence in dermatology, use of other 
preferred sources, and time pressure. PCPs who expressed confidence felt less need for 
information-seeking. Some had taken additional course work in dermatology, which increased 
their confidence and reduced their CET use. Use of other evidence sources instead of VisualDx 
also deterred CET use. Some did not always choose VisualDx as their first or only source despite 
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the trial protocol. Instead, PCPs felt that colleagues and other CETs, such as print textbooks, 
UpToDate, drug databases, and Internet images, would be better at times. Furthermore, 
perceived lack of time in a patient encounter prevented PCPs from seeking answers from any 
information source, even when they recognized uncertainty. Instead, they sometimes used a “try 
this and see if it works” approach. 
Step 2: Acquire Evidence  
Facilitators to using the CET at this step were access to the CET through the EHR and perceived 
overall ease of use of the CET. The EHR was almost always the only means by which PCPs 
accessed VisualDx, as it was convenient to access quickly from the desktop computers in patient 
exam rooms. Although the CET mobile version was available on smart phones and tablets, PCPs 
did not use it for patient care. Several stated they found the VisualDx interface easy to learn and 
use, though there was a “small learning curve”. 
 Despite its overall ease of use, the main barrier to CET use at this step was interface 
difficulties. About half of PCPs found the CET’s interactive diagnosis tool confusing, “not user 
friendly”, and unpredictable. Some lacked confidence in their ability to use the CET effectively 
even though they viewed a training tutorial as part of their enrollment in the trial. One PCP 
reported loss of access through the EHR after 1 month in the trial and did not return to using the 
resource even though she received assistance from a technical help desk.  
Step 3: Appraise Evidence for Quality and Relevance  
Facilitators to using the CET at this step were the availability of good quality evidence, 
assistance in patient diagnosis, and treatment decision support. PCPs appraised VisualDx 
information as good and reliable because it was validated by expert dermatologists. They knew it 
was more reliable than images on Internet search engines, to which “anybody…can upload a 
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picture”. None described seeking higher levels of evidence, such as diagnostic tools evaluated in 
randomized trials usually found in the journal literature. The CET’s relevance to diagnosis 
emerged in support of differential diagnosis expansion and confirmation of diagnosis. Residents 
found the CET’s interactive diagnostic tool particularly relevant when they had little idea of the 
diagnosis and needed to broaden the differential. Experienced physicians more often wanted to 
confirm a diagnosis, which VisualDx supported at times. With confirmation, PCPs were more 
likely to treat the problem themselves and avoid a referral. There were also situations in which 
diagnosis confirmation prompted a referral. Furthermore, new treatments described in the CET 
affected some PCPs’ treatment decisions and served to update their usual practice.  
 Barriers to using the CET at this step included the presence of irrelevant information. 
PCPs often retrieved too much information, requiring time-consuming information-sifting or a 
new search. Experienced clinicians, in particular, felt that the range of diagnoses and images 
retrieved was excessively broad, making it difficult to narrow the differential or confirm the most 
likely diagnosis. In addition, PCPs considered the CET as one information source among others 
to assist with the management of skin conditions, even though other sources are not optimized 
for this topic. VisualDx was used as “just one tool” among others or a corroborator of evidence 
found in another source. 
Step 4: Apply Evidence to and with Patient  
Facilitators to using the CET at this step were patient communication and shared decisions. PCPs 
found VisualDx images and information applicable for patient education and building rapport. 
The images helped them show patients how their condition had improved, which enhanced 
agreement on treatments and patient confidence. A few PCPs found the dermatology images too 
graphic to show patients but did share the information found. Some shared a full range of 
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VisualDx information with patients, including alternative diagnoses and multiple images, in a 
shared decision-making process.  
 The main barrier to using the CET at this step was a lack of evidence found that applied 
to a particular patient. Despite positive examples of communication with patients, many PCPs 
did not recall any real impact of using the CET with patients. That is, the information retrieved 
was relevant in a general way but did not aid in making decisions or offering a “different path 
forward” from what the PCP would have done anyway.  
 
Table 3: Representative PCP statements related to facilitators and barriers to CET use 
aligned with behavioral EBM steps 
Step 1: Ask a 
clinical 
question 
Theme  Provider Statements  
 Facilitators Intention to use 
CET 
“I think I used it close to every time I saw a skin problem, 
unless it was super obvious…But even then, I would use it to 
get treatment recommendations.” PCP08 (Resident, 3 years) 
 
“When I had a patient that had a skin complaint, I was 
supposed to open VisualDx… I tried to be pretty diligent about 
it.” PCP01 (Resident, 1 year) 
 Uncertainty in 
dermatology  
“[Dermatology] is way harder because we just don’t have the 
exposure. … So, I think something like VisualDx is totally 
necessary.” PCP07 (Resident, 3 years) 
 
“There are certain areas, [like dermatology] where internists in 
particular, don't have as much training and we tend to fall 
into…less rigorous ways of approaching a diagnosis.” PCP10 
(Attending, 22 years) 
 
Barriers Confidence in 
dermatology  
“If it's a simple thing that … you feel like you know what it is 
and how to treat it, then you obviously wouldn’t use the 
resource in that situation.” PCP02 (Attending, 32 years) 
 
“There were a lot of patients where I felt comfortable with 
what the problem was.” PCP11 (Attending, 24 years)  
 Other preferred 
information 
sources  
“I was working…next to a skilled, older practitioner. So often 
times my first recourse would be going to him.” PCP09 




“I used UpToDate quite frequently. And I used Micromedex 
quite frequently…I don’t think my use of VisualDx changed 
my rates of use of those other resources.” PCP08 (Resident, 3 
years) 
 
“I have a favorite dermatology book that I use like I would use 
VisualDx.” PCP10 (Attending, 22 years) 
 




“When you are already 45 minutes behind schedule and 
someone comes in with an [odd] rash, “It’s easy to say, I think 
it’s this, try it, if it doesn’t work call me back”.” PCP10 





Facilitators EHR access “If I’m seeing patients, I’m already in the EMR, and VisualDx 
is there. It’s easy to find. 99% of the time that’s what I’d do.” 
PCP11 (Attending, 24 years)  
  CET interface “Once I knew what I was doing it, it wasn’t hard to use.” 
PCP06 (Attending, 4 years)  
 Barrier CET interface “I remember staring at it saying, “Where do I put the 
information in?” So, it wasn’t as user friendly for data input” 
PCP10 (Attending, 22 years) 
 
“I'm not sure if I’m just not putting in enough [information]” 







Facilitators Quality of 
evidence 
“I had a lot of confidence that the material was accurate and 
properly edited or authenticated by experts in the field…” 
PCP03 (Attending, 34 years) 
 
“The problem with Google Images is [that] anybody…can 
upload a picture and tag it with a diagnosis.” PCP10 
(Attending, 22 years)  
Diagnosis 
support  
“I did, on a few occasions have no idea what I was looking at 
in a patient, and used [VisualDx]…to figure it out.” PCP08 




“I can definitely say it helped me feel more confident about a 
diagnosis.” PCP02 (Attending, 32 years) 
 
“I did, on a few occasions, have no idea what I was looking at 
in the patient and used it to try to figure it out.” PCP08 
(Resident, 3 years) 
 
“…I would often look at a skin lesion or rash and have an 
idea…and then …VisualDx would broaden my differential and 
sometimes completely change my initial opinion.” PCP07 
(Resident, 3 years) 
 Treatment 
support 
“A lady came in with something strange on her eyes …. Based 
on using VisualDx I came up with something I hadn’t 
considered. That did prompt a referral to dermatology.” PCP01 
(Resident, 1 year) 
 
“I think it changed my rate of dermatology referrals because I 
willing to diagnose skin conditions with…more confidence 
and to act on those diagnoses.” PCP08 (Resident, 3 years) 
 Barriers Presence of 
irrelevant 
information 
“Just as frequently as I found that it was helpful, I found that it 
was not helpful at all…I mostly got a lot of extraneous 
information and things that…weren't appropriate for what I 
was looking for…So some of that time using it was wasted.” 
PCP08 (Resident, 3 years) 
 
“If you put basal cell carcinoma in VisualDx, it’s a thousand 
pictures of every possible way it can show up. It’s not showing 
the typical ones.” PCP03 (Attending, 34 years) 
 
“I remember getting more hits back…a lot more diagnoses - 
than I was expecting -- some of which didn't even look close to 
what I described.” PCP10 (Attending, 22 years) 
 Other preferred 
information 
sources 
“If I knew what the [diagnosis] was but didn’t know how to 
manage it, I might use UpToDate [more].” PCP11 (Attending, 
24 years)  
 
“…If I thought of something, I’d look it up on UpToDate 
[also] and see if the pictures and descriptions matched 
[VisualDx]” PCP06 (Attending, 4 years) 
Step 4: Apply 
to and with 
patient 
  
 Facilitators Patient 
communication 
“I used it with patients, especially if they had something that 
went away; then they could say, “Oh, it did look like that”.” 




“Helpful for patient communication? Absolutely.” PCP04 
(Attending, 17 years)  
 
“…If you can use a visual to show somebody and say, "Oh this 
looks like really what you have," they gain a little bit more 




“I would open it up in the patient room oftentimes, and go 
through it [all] with them.” PCP06 (Attending, 4 years) 
 
“I would look at VisualDx and it would give me additional 
ideas. So, then I would talk to the patient more, come up with a 
diagnosis…” PCP08 (Resident, 3 years) 
 Barrier No impact on 
patient care 
“I can't think of a particular instance where it clinched it for 
me or made a clinical decision distinction or difference. It was 
more of a tool that I used to augment whatever I was looking 
into.” PCP09 (Attending, 4 years) 
 
 “Care difference? I would have to say no, that it didn't really 
offer me a different path forward.” PCP03 (Attending, 34 
years) 
 
“… If I was going to refer to dermatology, I [would] refer to 
dermatology. [VisualDx] wouldn't change my mind.” PCP04 
(Attending, 17 years) 
 
Mixed Methods Results Integration 
When combined, the quantitative survey and qualitative interview results provide a more 
complete picture of how PCPs sought and used VisualDx and other information sources to 
manage skin problems in patients. The interviews provided context related to each behavioral 
step of EBM for the survey responses pertaining to frequency of use, ease of use, and usefulness 
for patient care and identified specific barriers and facilitators to CET use. When we compared 
four survey variables (usage of the CET, ease of use, usefulness, and use of other information 
sources) with the interview themes and sub-themes at the behavioral steps, most comparisons 
reflected complementarity, such that the interview statements did not contradict but rather 






Table 4: Integration of mixed methods 
 
Behavioral step  Survey Results Triangulation Interview Results: 
Barriers (B) and 
Facilitators (F) 
Step 1: Ask a 
clinical question 
PCPs used the 
CET a median of 
10 times; less 
experienced PCPs 
used the CET a 
median of 15 
times. 
Complementarity PCPs expressed 
intention and 
frequent usage (F) 
 46% of PCPs used 
the CET with most 
patients. 




expressed a lack of 
need and lower 
usage (B), whereas 
uncertainty signaled 
more need and 
usage (F). 
Step 2: Acquire 
evidence  
77% of PCPs 
found the CET 
somewhat or very 




All but one PCP 
found CET access 
through the EHR to 
be easy (F). The 
CET interface was 
easy to use for about 
half of PCPs (F). 
 No data on CET 




About half of PCPs 
reported that the 
interactive diagnosis 
tool was difficult 
and unpredictable at 
times (B). 
Step 3: Appraise 
evidence for quality 
and relevance  





PCPs expressed that 
the quality of 
evidence in the CET 
was satisfactory (F). 
 62% of PCPs 
reported that the 
CET was not 
useful or 
occasionally useful 




PCPs expressed that 
the CET was 







38% reported that 
it was usually 
useful.  
treatment discovery 
(F). Others said it 
was “just as often” 
irrelevant or 
unhelpful (B). 
 67% of PCP used 
VisualDx in a 
recent month post-
trial.  
Complementarity PCPs reported that 
other information 
sources were as or 
more useful than the 
CET (B). 
Step 4: Apply 
evidence to and with 
patient  
No specific data on 
application to 
patients. 
Silence PCPs expressed that 
the CET facilitated 
patient education 
and shared decisions 
(F) and prompted 
and avoided 
referrals (F) but had 





This study identified facilitators and barriers to effective use of a dermatology-focused CET for 
skin problem management in the context of patient care from the perspective of PCPs. It also 
identified possible reasons why use of the CET did not impact patient outcomes in the original 
trial. The brief closed-answer survey of PCPs provided summary information on the number of 
times used, ease of use, and usefulness of the CET. Barriers and facilitators identified in 
interviews enriched our understanding of the complex behavioral EBM steps that influence use 
of a CET. Integration of the results of mixed methods provided complementary insights. 
Barriers and Facilitators to CET Use in Evidence-Based Practice 
Multiple barriers to the use of clinical evidence sources by PCPs have been described in the 
literature over the last decades. In two studies of PCPs, Ely et al. identified lack of time to seek 
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and acquire needed information and lack of skill as barriers [5, 26]. Ely et al. also identified the 
retrieval of too much information and the irrelevance of the retrieved information as problems. In 
a focus group study of primary care internal medicine residents, poor access to technology and 
lack of relevant sources in the practice setting were barriers [7]. These same barriers were also 
identified in the present study. In addition, a qualitative study identified the barrier of failure of 
the evidence sources to account for patient complexity [27]. A 2012 systematic review including 
22 studies published between 1997 and 2010 reported barriers to EBM practice at each 
behavioral step that were similar to those reported in previous literature except for a novel barrier 
at the Apply Evidence step: patient disagreement with best evidence [28]. An additional barrier 
identified in our study was PCP confidence in the dermatology domain. 
Cook et al. identified multiple facilitators in a study that identified strengths of 
“knowledge resources” (i.e., CETs). Effective sources were found to be efficient, credible, 
integrated with the clinical workflow, familiar to the user, optimized for the topic, and supportive 
of patient education [29]. In our study, convenient access to VisualDx through the EHR partially 
overcame the barrier of time pressure. The ability to include patient factors in the interactive 
diagnosis tool partially accounted for relevance to complex patient characteristics. However, the 
unpredictability of search results decreased efficiency and reduced the benefit of using VisualDx 
as opposed to other familiar sources. Utility for patient communication, education, and shared 
decision-making emerged as benefits when evidence was applied with patient preferences and 
values, an essential step in evidence-based practice. 
 Seeking information from multiple sources for the same clinical question is typical 
behavior for clinicians [2, 30]. One study noted that 3.5 CET sources were typically referenced 
per question [30]. In our study, PCPs preferred multiple CETs if they were convenient. The 
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presence of other sources diluted the impact of VisualDx and reduced the likelihood of detecting 
any effects of CET use on patient outcomes in the original trial.  
It is possible that evidence-seeking in CETs may be less frequent or more difficult in 
dermatology. In a qualitative study of PCP strategies for diagnosing skin problems, preferred 
strategies included pattern recognition, “trying out” treatments, and referral to dermatology. 
Consulting research-based literature or online sources was seldom used as a strategy [31]. In the 
present study, nearly half of PCPs in the CET arm reported using VisualDx with most of their 
patients with skin problems, and they frequently used other evidence sources if convenient. This 
study did not identify any dermatology evidence source as superior to VisualDx, only that PCPs 
used it among other CETs for dermatological problem management.  
 Our results suggest that VisualDx may be more useful to trainees and new attending 
PCPs than those with more experience. Less experienced PCPs seemed to express more ease 
using the CET, recognized more uncertainty in dermatology, and expressed need for tools like 
VisualDx. For these users, expansion of the differential diagnosis with use of the patient-specific 
interactive diagnosis tool facilitated point-of-care learning.  
Effect on Patient-level Outcomes  
Why did VisualDx use make no difference in the outcomes reported in the original study? It is 
possible that the effects were bi-directional. For instance, some PCPs reported that VisualDx use 
affected referral patterns. For some, the evidence found for a diagnosis prompted referrals to 
dermatology. For others, a referral was avoided, and the clinician gained confidence in treating 
the condition. This effect may partially explain why use of the CET did not reduce the overall 
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number of patient return appointments (including referrals) for the same skin problem (odds ratio 
= 1.26, 95% confidence interval = 0.70 -1.21, p = 0.54) [15].  
Likewise, three other intervention studies found that use of a CET did not reduce referrals 
to dermatology [13, 32, 33]. While reduction of referrals and other return appointments may be a 
clinical goal to save patient and provider time and to reduce costs, its attainment through usage 
of CETs has not been established. It is possible that patient communication with use of the CET 
could have affected patient satisfaction with care, which could be evaluated in future research.  
Implications For Evaluation of CETs  
Although this study focused on one CET, the barriers and facilitators to its use may be applicable 
in the evaluation of other CETs implemented for point-of-care use. We identified ways that a 
single CET may have value for provider management of patient conditions, such as diagnostic 
accuracy and identification of best treatments. A CET may also facilitate point-of-care learning 
and shared decision-making with patients.  
Health sciences librarians directly support the Acquire step in the EBM model by 
licensing and providing access to clinical evidence sources. When choosing and licensing CETs, 
medical librarians should consider the factors of clinician population, access technology, and 
available evidence sources in addition to cost. A CET licensed and implemented for clinical use 
should be accessible through the EHR to increase clinician acceptance. Less experienced 
clinicians and residents may have different CET use patterns than more experienced PCPs. 
Furthermore, use of more than source may be needed to meet clinicians’ clinical evidence needs 




Our study has several limitations that should be considered. It did not include reports from 
patients, limiting the interpretations to the perceptions and experience of PCPs. Recall errors 
may have affected the reported data, but all PCPs appeared to respond to survey and interview 
questions without difficulty. The interviews were conducted by a medical librarian known to 
some of the PCPs outside the study, which could have introduced bias. However, all PCPs 
agreed to give their true opinions and were assured that their responses would be confidential 
and would not affect their access to medical library services. In addition, the study took place in 
one academic medical center, limiting its generalizability to other settings.  
Conclusion 
We identified facilitators and barriers to PCPs’ use of a CET for skin problems in the context of 
patient care, which partially explain the results of a previous cluster-randomized controlled trial. 
We found that the CET was not consistently useful to PCPs or applicable to patients. However, it 
did support some diagnosis and treatment decisions, point-of-care learning, and patient 
communication and shared decision-making. These findings could be useful to clinical 
administrators and medical librarians considering implementation of CETs to support the 
management of dermatological conditions in primary care settings.  
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